DNMT3A and TET2 compete and cooperate to repress lineage-specific transcription factors in hematopoietic stem cells

[1]  P. Gaulard,et al.  DNMT3AR882H mutant and Tet2 inactivation cooperate in the deregulation of DNA methylation control to induce lymphoid malignancies in mice , 2016, Leukemia.

[2]  A. Rao,et al.  Acute loss of TET function results in aggressive myeloid cancer in mice , 2015, Nature Communications.

[3]  Zhaohui S. Qin,et al.  Combined Loss of Tet1 and Tet2 Promotes B Cell, but Not Myeloid Malignancies, in Mice. , 2015, Cell reports.

[4]  Tariq Enver,et al.  Primed and ready: understanding lineage commitment through single cell analysis. , 2015, Trends in cell biology.

[5]  B. Porse,et al.  Loss of TET2 in hematopoietic cells leads to DNA hypermethylation of active enhancers and induction of leukemogenesis , 2015, Genes & development.

[6]  Chuan He,et al.  Molecular Basis for 5-Carboxycytosine Recognition by RNA Polymerase II Elongation Complex , 2015, Nature.

[7]  R. Jaenisch,et al.  TET1 is a tumor suppressor of hematopoietic malignancy , 2015, Nature Immunology.

[8]  Wei Li,et al.  Dnmt3a loss predisposes murine hematopoietic stem cells to malignant transformation. , 2015, Blood.

[9]  M. McCarthy,et al.  Age-related clonal hematopoiesis associated with adverse outcomes. , 2014, The New England journal of medicine.

[10]  Christopher A. Miller,et al.  Enforced differentiation of Dnmt3a-null bone marrow leads to failure with c-Kit mutations driving leukemic transformation. , 2014, Blood.

[11]  S. Gabriel,et al.  Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence. , 2014, The New England journal of medicine.

[12]  Wei Li,et al.  Dnmt3a and Dnmt3b have overlapping and distinct functions in hematopoietic stem cells. , 2014, Cell stem cell.

[13]  A. Quinlan.  BEDTools: The Swiss‐Army Tool for Genome Feature Analysis , 2014, Current protocols in bioinformatics.

[14]  N. Friedman,et al.  Chromatin state dynamics during blood formation , 2014, Science.

[15]  Harri Lähdesmäki,et al.  Dissecting the dynamic changes of 5-hydroxymethylcytosine in T-cell development and differentiation , 2014, Proceedings of the National Academy of Sciences.

[16]  R. Fulton,et al.  The R882H DNMT3A mutation associated with AML dominantly inhibits wild-type DNMT3A by blocking its ability to form active tetramers. , 2014, Cancer cell.

[17]  Thomas J. Hudson,et al.  Corrigendum: Identification of pre-leukaemic haematopoietic stem cells in acute leukaemia , 2014, Nature.

[18]  J. Zuber,et al.  Stage-specific control of early B cell development by the transcription factor Ikaros , 2014, Nature Immunology.

[19]  I. Weissman,et al.  Preleukemic mutations in human acute myeloid leukemia affect epigenetic regulators and persist in remission , 2014, Proceedings of the National Academy of Sciences.

[20]  Wei Li,et al.  MOABS: model based analysis of bisulfite sequencing data , 2014, Genome Biology.

[21]  R. Grossman,et al.  Hydroxymethylation at gene regulatory regions directs stem/early progenitor cell commitment during erythropoiesis. , 2014, Cell reports.

[22]  I. Lossos,et al.  Recurrent mutations in epigenetic regulators, RHOA and FYN kinase in peripheral T cell lymphomas , 2014, Nature Genetics.

[23]  O. Nureki,et al.  Somatic RHOA mutation in angioimmunoblastic T cell lymphoma , 2014, Nature Genetics.

[24]  Marie S. Hasemann,et al.  C/EBPα Is Required for Long-Term Self-Renewal and Lineage Priming of Hematopoietic Stem Cells and for the Maintenance of Epigenetic Configurations in Multipotent Progenitors , 2014, PLoS genetics.

[25]  Wei Li,et al.  Large conserved domains of low DNA methylation maintained by Dnmt3a , 2013, Nature Genetics.

[26]  S. Orkin,et al.  Mapping cellular hierarchy by single-cell analysis of the cell surface repertoire. , 2013, Cell stem cell.

[27]  A. Gnirke,et al.  Charting a dynamic DNA methylation landscape of the human genome , 2013, Nature.

[28]  Brian J. Smith,et al.  Structure-guided design of a selective BCL-X(L) inhibitor. , 2013, Nature chemical biology.

[29]  Benjamin J. Raphael,et al.  Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. , 2013, The New England journal of medicine.

[30]  J. Shu,et al.  Induction of Pluripotency in Mouse Somatic Cells with Lineage Specifiers , 2013, Cell.

[31]  Yi Zhang,et al.  Genome-wide Analysis Reveals TET- and TDG-Dependent 5-Methylcytosine Oxidation Dynamics , 2013, Cell.

[32]  A. Kohlmann,et al.  The molecular profile of adult T‐cell acute lymphoblastic leukemia: Mutations in RUNX1 and DNMT3A are associated with poor prognosis in T‐ALL , 2013, Genes, chromosomes & cancer.

[33]  Zhaoyu Li,et al.  DANPOS: Dynamic analysis of nucleosome position and occupancy by sequencing , 2013, Genome research.

[34]  M. Goodell,et al.  Flow cytometry analysis of murine hematopoietic stem cells , 2013, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[35]  Benjamin Dartigues,et al.  Novel roles for KLF1 in erythropoiesis revealed by mRNA-seq , 2012, Genome research.

[36]  William A. Pastor,et al.  The anti-CMS technique for genome-wide mapping of 5-hydroxymethylcytosine , 2012, Nature Protocols.

[37]  Joshua F. McMichael,et al.  The Origin and Evolution of Mutations in Acute Myeloid Leukemia , 2012, Cell.

[38]  Christian Bastard,et al.  TET2 and DNMT3A mutations in human T-cell lymphoma. , 2012, The New England journal of medicine.

[39]  A. Ferrando,et al.  ETV6 mutations in early immature human T cell leukemias , 2011, The Journal of experimental medicine.

[40]  J. Berg,et al.  Dnmt3a is essential for hematopoietic stem cell differentiation , 2011, Nature Genetics.

[41]  Wenyong Zhang,et al.  Deletion of Tet2 in mice leads to dysregulated hematopoietic stem cells and subsequent development of myeloid malignancies. , 2011, Blood.

[42]  Yi Zhang,et al.  Replication-Dependent Loss of 5-Hydroxymethylcytosine in Mouse Preimplantation Embryos , 2011, Science.

[43]  K. Rajewsky,et al.  Ten-Eleven-Translocation 2 (TET2) negatively regulates homeostasis and differentiation of hematopoietic stem cells in mice , 2011, Proceedings of the National Academy of Sciences.

[44]  O. Abdel-Wahab,et al.  Tet2 loss leads to increased hematopoietic stem cell self-renewal and myeloid transformation. , 2011, Cancer cell.

[45]  P. Opolon,et al.  TET2 inactivation results in pleiotropic hematopoietic abnormalities in mouse and is a recurrent event during human lymphomagenesis. , 2011, Cancer cell.

[46]  Philipp Kapranov,et al.  Genome-wide mapping of 5-hydroxymethylcytosine in embryonic stem cells , 2011, Nature.

[47]  Juri Rappsilber,et al.  TET1 and hydroxymethylcytosine in transcription and DNA methylation fidelity , 2011, Nature.

[48]  W. Reik,et al.  Dynamic regulation of 5-hydroxymethylcytosine in mouse ES cells and during differentiation , 2011, Nature.

[49]  J. Licht,et al.  DNMT3A mutations in acute myeloid leukemia , 2011, Nature Genetics.

[50]  Keji Zhao,et al.  Dual functions of Tet1 in transcriptional regulation in mouse embryonic stem cells , 2011, Nature.

[51]  Li Ding,et al.  Recurrent DNMT3A Mutations in Patients with Myelodysplastic Syndromes , 2011, Leukemia.

[52]  Xia Li,et al.  QDMR: a quantitative method for identification of differentially methylated regions by entropy , 2011, Nucleic acids research.

[53]  J. Licht,et al.  Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation. , 2010, Cancer cell.

[54]  L. Aravind,et al.  Impaired hydroxylation of 5-methylcytosine in myeloid cancers with mutant TET2 , 2010, Nature.

[55]  Michael R. Tallack,et al.  A global role for KLF1 in erythropoiesis revealed by ChIP-seq in primary erythroid cells. , 2010, Genome research.

[56]  David R. Liu,et al.  The Behaviour of 5-Hydroxymethylcytosine in Bisulfite Sequencing , 2010, PloS one.

[57]  J. Soulier,et al.  Mutation in TET2 in myeloid cancers. , 2009, The New England journal of medicine.

[58]  D. Gilliland,et al.  Genetic characterization of TET1, TET2, and TET3 alterations in myeloid malignancies. , 2009, Blood.

[59]  David R. Liu,et al.  Conversion of 5-Methylcytosine to 5-Hydroxymethylcytosine in Mammalian DNA by MLL Partner TET1 , 2009, Science.

[60]  Clifford A. Meyer,et al.  Model-based Analysis of ChIP-Seq (MACS) , 2008, Genome Biology.

[61]  Steven B. Bradfute,et al.  Hematopoietic fingerprints: an expression database of stem cells and their progeny. , 2007, Cell stem cell.

[62]  Brad T. Sherman,et al.  The DAVID Gene Functional Classification Tool: a novel biological module-centric algorithm to functionally analyze large gene lists , 2007, Genome Biology.

[63]  J. Mesirov,et al.  From the Cover: Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005 .

[64]  S. Orkin.  Priming the hematopoietic pump. , 2003, Immunity.

[65]  S. Rombauts,et al.  Analysis of RNA-Seq data with TopHat and Cufflinks for genome-wide expression analysis of jasmonate-treated plants and plant cultures. , 2013, Methods in molecular biology.

[66]  Yuanxin Xi,et al.  BMC Bioinformatics BioMed Central Methodology article BSMAP: whole genome bisulfite sequence MAPping program , 2009 .